Article
Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program.
Journal of the American Heart Association - 3 Dec 2024
Bhatt Kunal, Delgado Diego H, Khella Sami, Bumma Naresh, Karam Chafic, Keller Andrew, Rosen Andrew M, Bozas Ana, Shea Amy, Towne Meghan C, Polfus Linda M, Kaeser Gwendolyn E, Sanjurjo Victoria, Shah Keyur B
Abstract excerpt
BACKGROUND: Diagnosis of hereditary amyloid transthyretin (hATTR) amyloidosis with cardiomyopathy is frequently delayed, in large part because of symptom overlap with other cardiovascular diseases and limited provider knowledge of this disease. The sponsored and provider referred hATTR Compass Genetic Testing Program (Ionis, Carlsbad, CA; Ambry Genetics, Aliso Viejo, CA) provided no-cost genetic testing to adults...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
